Evaluating the technical feasibility of aflatoxin risk reduction strategies in Africa.
Public health interventions must be readily accepted by their target populations to have any meaningful impact and must have financial and infrastructural support to be feasible in the parts of the world where they are most needed. At the same time, these interventions must be assessed for potential unintended consequences, either to the environment or to human health. In this paper, we evaluate the technical feasibility of interventions to control aflatoxin risk, to be potentially deployed in parts of Africa where aflatoxin exposure poses a significant public health concern. We have applied a conceptual framework for feasibility to four interventions, one associated with each of four different stages of aflatoxin risk: biocontrol (pre-harvest), a post-harvest intervention package (post-harvest), NovaSil clay (dietary), and hepatitis B vaccination (clinical). For each intervention, we have assessed the following four components of technical feasibility: (1) characteristics of the basic intervention, (2) characteristics of delivery, (3) requirements on government capacity, and (4) usage characteristics. We propose ways in which feasibility of each intervention is currently high or low from the perspective of adoption in Africa, how public education is crucial for each of these interventions to succeed, and how to align economic incentives to make the interventions more suitable for less developed countries.
Wu
Felicia
F
Department of Environmental and Occupational Health, University of Pittsburgh, Pittsburgh, PA 15219, USA. few8@pitt.edu
Khlangwiset
Pornsri
P
D000348:Aflatoxins / Q000096:biosynthesis / Q000592:standards / Q000633:toxicity*; D000349:Africa; D000383:Agriculture / Q000191:economics / Q000331:legislation & jurisprudence / Q000379:methods; D010367:Arachis / Q000737:chemistry / Q000382:microbiology; D001230:Aspergillus / Q000378:metabolism*; D018556:Crops, Agricultural / Q000737:chemistry* / Q000382:microbiology*; D003906:Developing Countries / Q000191:economics; D004032:Diet; D002523:Edible Grain / Q000737:chemistry / Q000382:microbiology; D005240:Feasibility Studies; D005506:Food Contamination / Q000517:prevention & control*; D005511:Food Handling / Q000191:economics / Q000331:legislation & jurisprudence / Q000379:methods; D005517:Foodborne Diseases / Q000517:prevention & control; D006291:Health Policy / Q000191:economics / Q000331:legislation & jurisprudence; D006293:Health Promotion; D017325:Hepatitis B Vaccines / Q000008:administration & dosage; D006801:Humans; D015980:Public Health Practice / Q000191:economics / Q000331:legislation & jurisprudence; D018570:Risk Assessment / Q000379:methods*
D000348:Aflatoxins; D017325:Hepatitis B Vaccines
Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2008 Feb;25(2):134-45
18286403
J Stored Prod Res. 2000 Oct 15;36(4):365-382
10880814
Food Addit Contam. 2005 Mar;22(3):270-9
16019795
Environ Sci Technol. 2004 Aug 1;38(15):4049-55
15352440
Environ Health Perspect. 2005 Dec;113(12):1779-83
16330363
Proc Natl Acad Sci U S A. 2001 Dec 4;98(25):14601-6
11724948
Toxicol Appl Pharmacol. 2008 Sep 1;231(2):142-9
18501398
Afr J Med Med Sci. 2006 Sep;35(3):337-43
17312742
Ann Soc Belg Med Trop. 1987 Sep;67(3):301
3442435
Mycopathologia. 2006 Sep;162(3):233-43
16944290
Science. 1999 Dec 24;286(5449):2453-4
10636808
Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2008 Jan;25(1):76-87
17852392
Environ Health Perspect. 2006 Dec;114(12):1898-903
17185282
Int Immunol. 2005 Jun;17(6):807-14
15944194
Appl Environ Microbiol. 1994 Jul;60(7):2248-51
8074506
Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2008 May;25(5):622-34
18478481
Mycoses. 2009 May;52(3):206-22
19207851
J Obstet Gynaecol. 2001 Nov;21(6):583-6
12521773
Rev Inst Med Trop Sao Paulo. 2008 Jul-Aug;50(4):219-21
18813761
BMJ. 1991 Feb 9;302(6772):313-6
1825799
Appl Microbiol Biotechnol. 2004 Sep;65(4):473-8
15235754
J Nutr. 2001 Nov;131(11 Suppl):3027S-33S
11694642
Mutat Res. 2000 Apr;462(2-3):381-93
10767647
J Food Prot. 1999 Jun;62(6):650-6
10382655
Risk Anal. 2009 Oct;29(10):1395-409
19659555
Food Addit Contam. 2007 Oct;24(10):1109-14
17886182
Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2008 Oct;25(10):1264-71
18608502
Annu Rev Public Health. 2008;29:187-203
17914931
Cancer Epidemiol Biomarkers Prev. 2005 Nov;14(11 Pt 1):2605-13
16284385
Microbiology (Reading). 2007 Jun;153(Pt 6):1677-1692
17526826
Mycologia. 2009 May-Jun;101(3):423-9
19537215
Epidemiol Prev. 1997 Apr-Jun;21(2):129-36
9378180
Lancet. 2005 Jun 4-10;365(9475):1950-6
15936422
Gut. 1996;38 Suppl 2:S5-12
8786055
Cancer Res. 1990 Jan 15;50(2):245-51
2104776
Environ Health Perspect. 2003 Feb;111(2):217-20
12573908
Am J Clin Nutr. 2004 Nov;80(5):1106-22
15531656
Environ Health Perspect. 2008 Nov;116(11):1553-7
19057710
Clin Dev Immunol. 2008;2008:790309
18695741
J Toxicol Environ Health B Crit Rev. 2000 Apr-Jun;3(2):109-43
10834078
Cancer Epidemiol Biomarkers Prev. 1994 Jan-Feb;3(1):3-10
8118382
Mem Inst Oswaldo Cruz. 2005 Feb;100(1):13-6
15867956
Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2010 Apr;27(4):496-509
20234965
Carcinogenesis. 2008 Feb;29(2):411-7
18192689
Int J Hyg Environ Health. 2006 Jul;209(4):345-58
16644281
Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2010 Jul;27(7):998-1014
20419532
Br J Biomed Sci. 2007;64(4):177-9
18236741
Bull World Health Organ. 2005 Apr;83(4):285-93
15868020
BMJ. 2002 Jul 6;325(7354):20-1
12098724
Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2008 Oct;25(10):1246-56
18608489